1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Active Hyperemia in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cardiovascular diseases are associated with chronic activation of Rho-associated kinases (ROCKs) and endothelial dysfunction." | 1.37 | Rho-associated kinase activity, endothelial function, and cardiovascular risk factors. ( Chayama, K; Fujii, Y; Fujimura, N; Hata, T; Hidaka, T; Higashi, Y; Idei, N; Kato, H; Kihara, Y; Liao, JK; Maruhashi, T; Mikami, S; Noma, K; Soga, J, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soga, J | 1 |
| Noma, K | 1 |
| Hata, T | 1 |
| Hidaka, T | 1 |
| Fujii, Y | 1 |
| Idei, N | 1 |
| Fujimura, N | 1 |
| Mikami, S | 1 |
| Maruhashi, T | 1 |
| Kihara, Y | 1 |
| Chayama, K | 1 |
| Kato, H | 1 |
| Liao, JK | 1 |
| Higashi, Y | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Active Hyperemia
| Article | Year |
|---|---|
Rho-associated kinase activity, endothelial function, and cardiovascular risk factors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Aged; Blood Pressure; Blotting, Western; Body | 2011 |